Jul 1, 2024

9th Microbiome Movement – Drug Development Summit

Dr. Elran Haber, CEO of Biomica, will be participating as a panelist at the 9th Microbiome Movement – Drug Development Summit. On July 12th at 9:30 am ET, Dr. Haber will engage in the panel discussion “Defining Innovative Clinical Strategies Conserving Spend.” This discussion will explore adaptive trial methodologies, strategic partnerships, and criteria for attracting investor attention in microbiome drug development.

Back to all News

Highlighted News About Biomica

Microbiome Times Partnering Forum
Mar 17, 2025

Microbiome Times Partnering Forum

Biomica’s CEO, Dr. Elran Haber, is heading to Brussels this week for the Microbiome Times Partnering Forum – a key event for advancing microbiome-based therapeutics through strategic partnerships. More info & registration: www.microbiomeforum.com

Feb 27, 2025

MIXiii Health-Tech.IL 2025

Dr. Elran Haber, Biomica’s CEO, will attend MIXiii Health-Tech.IL 2025 on March 4-5 at ICC Jerusalem. This leading Israeli health-tech conference unites industry leaders, startups, and investors to explore innovations in personalized medicine, AI-driven drug development, cancer treatment, and more. More info & registration: www.mixiii.com